Reji Kakkassery serves as a Principal Research Engineer (Software) at Abbott Diagnostics Business, where he plays a pivotal role in the Research & Development team, focusing on innovative solutions that enhance diagnostic capabilities in the healthcare sector. With extensive experience in the hospital and healthcare...
Reji Kakkassery serves as a Principal Research Engineer (Software) at Abbott Diagnostics Business, where he plays a pivotal role in the Research & Development team, focusing on innovative solutions that enhance diagnostic capabilities in the healthcare sector. With extensive experience in the hospital and healthcare industry, Reji has honed his expertise in software development and project management, contributing significantly to the advancement of medical devices. His work primarily revolves around the Alinity ci-series analyzers, a suite of fully automated high-throughput systems designed for Clinical Chemistry and Immunoassay testing, as well as the Alinity s Analyzer, which specializes in Blood and Plasma Screening.
In his current role, Reji leads cross-functional teams through the software development life cycle (SDLC), employing Agile methodologies to ensure timely and efficient project execution. His strong engineering background enables him to navigate complex integration challenges, ensuring that software solutions are not only robust but also compliant with stringent quality assurance standards. Proficient in programming languages such as C and adept in utilizing ObjectStore databases, Reji is instrumental in developing and testing software that drives the performance of Abbott's diagnostic instruments.
Reji's commitment to innovation and excellence is evident in his ability to manage multiple projects simultaneously while fostering collaboration among diverse teams. His insights into software testing and quality assurance processes contribute to the reliability and accuracy of diagnostic results, ultimately enhancing patient care. As a thought leader in the field, Reji continues to push the boundaries of technology in healthcare, making significant strides in the development of next-generation diagnostic systems.
